Illuminate and Wellstar Collaborate to Enhance Cerebral Aneurysm Surveillance

26 June 2024

Softek Illuminate, Inc., a provider of enterprise management and discovery software, has announced a new partnership with Wellstar, one of Georgia's largest health systems, to introduce the Discovery360 Cerebral Aneurysm (CA) program.

This collaboration expands on their existing efforts to enhance the identification and surveillance of Abdominal Aortic Aneurysms at Wellstar.

The goal of this initiative is to establish a comprehensive clinical surveillance process for incidentally discovered cerebral aneurysms and define new clinical parameters for effective patient management. Softek Illuminate will leverage their ActKnowlege Workflow Conscious AITM to swiftly:

  • Identify patients with cerebral aneurysms potentially missed in electronic health records (EHR), irrespective of explicit follow-up recommendations.
  • Prioritize patient care management based on health system-specific guidelines, considering factors like aneurysm size, location, and urgency of follow-up.

These advancements aim to improve patient outcomes, minimize treatment delays, and refine cerebral aneurysm surveillance programs.

Neurosurgeon at Wellstar, commented, "This partnership promises valuable clinical insights that will enhance cerebral aneurysm treatment and patient care.

Given the complexities and the incidental nature of cerebral aneurysms, this technology presents a significant opportunity to address gaps in neurovascular care and optimize treatment plans."

This announcement builds on Illuminate's existing capabilities in identifying various arterial aneurysms and underscores efforts to simplify the management of patients requiring critical vascular follow-up care.

Combining Illuminate's AI technology and clinical expertise, the Illuminate Discovery 360TM Platform integrates skilled nurse navigators experienced in patient follow-up and management workflows.

Their involvement aims to facilitate the implementation of comprehensive aneurysm surveillance programs and achieve the following benefits:

  • Enhance compliance with follow-up protocols.
  • Bridge gaps in patient care.
  • Align follow-up care with health system guidelines.
  • Improve patient retention within the network and reduce referral leakage.
  • Prevent ruptures and save lives.

Optimism about expanding their collaboration with Wellstar, emphasizing their AI's unique potential to enhance the management of incidentally discovered Cerebral Aneurysms.

This partnership aims to empower healthcare providers with proactive approaches and expanded treatment options for their patients.







Source: prnewswire.com